161 related articles for article (PubMed ID: 10647647)
1. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer.
Ornstein DK; Lubensky IA; Venzon D; Zbar B; Linehan WM; Walther MM
J Urol; 2000 Feb; 163(2):431-3. PubMed ID: 10647647
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
Walther MM; Lubensky IA; Venzon D; Zbar B; Linehan WM
J Urol; 1995 Dec; 154(6):2010-4; discussion 2014-5. PubMed ID: 7500446
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
4. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
Lubensky IA; Schmidt L; Zhuang Z; Weirich G; Pack S; Zambrano N; Walther MM; Choyke P; Linehan WM; Zbar B
Am J Pathol; 1999 Aug; 155(2):517-26. PubMed ID: 10433944
[TBL] [Abstract][Full Text] [Related]
5. Histopathology and molecular genetics of renal tumors toward unification of a classification system.
Zambrano NR; Lubensky IA; Merino MJ; Linehan WM; Walther MM
J Urol; 1999 Oct; 162(4):1246-58. PubMed ID: 10492174
[TBL] [Abstract][Full Text] [Related]
6. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.
Herring JC; Enquist EG; Chernoff A; Linehan WM; Choyke PL; Walther MM
J Urol; 2001 Mar; 165(3):777-81. PubMed ID: 11176466
[TBL] [Abstract][Full Text] [Related]
7. Hereditary and familial kidney cancer.
Coleman JA; Russo P
Curr Opin Urol; 2009 Sep; 19(5):478-85. PubMed ID: 19584731
[TBL] [Abstract][Full Text] [Related]
8. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
9. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
10. Pseudotumors after renal parenchymal sparing surgery.
Kshirsagar AV; Choyke PL; Linehan WM; Walther MM
J Urol; 1998 Apr; 159(4):1148-51. PubMed ID: 9507819
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
12. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
[TBL] [Abstract][Full Text] [Related]
13. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis in diagnosis and treatment of 11 patients with hereditary renal cell carcinoma].
Gong DX; Wang X; Li ZL; Jiang YJ; Sun ZX; Kong CZ
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(14):963-5. PubMed ID: 17074206
[TBL] [Abstract][Full Text] [Related]
15. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
Czene K; Hemminki K
J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
[TBL] [Abstract][Full Text] [Related]
16. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
Prat E; Bernués M; Del Rey J; Camps J; Ponsa I; Algaba F; Egozcue J; Caballín MR; Gelabert A; Miró R
Cancer Genet Cytogenet; 2006 Jan; 164(2):142-7. PubMed ID: 16434318
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of c-met over expression in papillary renal cell carcinoma.
Sweeney P; El-Naggar AK; Lin SH; Pisters LL
J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists.
García-Donas J; Hernando S; Romero N; Jara C
Anticancer Drugs; 2011 Jan; 22 Suppl 1():S15-20. PubMed ID: 21173603
[TBL] [Abstract][Full Text] [Related]
19. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
Grubb RL; Franks ME; Toro J; Middelton L; Choyke L; Fowler S; Torres-Cabala C; Glenn GM; Choyke P; Merino MJ; Zbar B; Pinto PA; Srinivasan R; Coleman JA; Linehan WM
J Urol; 2007 Jun; 177(6):2074-9; discussion 2079-80. PubMed ID: 17509289
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]